Ken Griffin’s Flexion Therapeutics, Inc. FLXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-266,575
| Closed | -$1.63M | – | 15474 |
|
|
2021
Q3 | $1.63M | Buy |
+266,575
| New | +$1.66M | ﹤0.01% | 6887 |
|
|
2021
Q2 | – | Sell |
-16,616
| Closed | -$141K | – | 14836 |
|
|
2021
Q1 | $149K | Sell |
16,616
-178,078
| -91% | -$2.04M | ﹤0.01% | 12049 |
|
|
2020
Q4 | $2.25M | Sell |
194,694
-43,066
| -18% | -$500K | ﹤0.01% | 5116 |
|
|
2020
Q3 | $2.48M | Sell |
237,760
-167,358
| -41% | -$2.05M | ﹤0.01% | 4325 |
|
|
2020
Q2 | $5.33M | Buy |
405,118
+163,874
| +68% | +$1.7M | ﹤0.01% | 3005 |
|
|
2020
Q1 | $1.9M | Sell |
241,244
-27,085
| -10% | -$408K | ﹤0.01% | 4223 |
|
|
2019
Q4 | $5.55M | Sell |
268,329
-33,811
| -11% | -$570K | ﹤0.01% | 2943 |
|
|
2019
Q3 | $4.14M | Buy |
302,140
+169,582
| +128% | +$2.01M | ﹤0.01% | 3368 |
|
|
2019
Q2 | $1.63M | Sell |
132,558
-178,352
| -57% | -$2.06M | ﹤0.01% | 4869 |
|
|
2019
Q1 | $3.88M | Buy |
310,910
+27,405
| +10% | +$366K | ﹤0.01% | 3356 |
|
|
2018
Q4 | $3.21M | Buy |
283,505
+186,086
| +191% | +$2.92M | ﹤0.01% | 3419 |
|
|
2018
Q3 | $1.82M | Buy |
+97,419
| New | +$2.24M | ﹤0.01% | 4571 |
|
|
2018
Q2 | – | Sell |
-157,062
| Closed | -$4.08M | – | 9472 |
|
|
2018
Q1 | $3.52M | Buy |
+157,062
| New | +$3.83M | ﹤0.01% | 2913 |
|
|
2017
Q4 | – | Sell |
-58,082
| Closed | -$1.42M | – | 8624 |
|
|
2017
Q3 | $1.4M | Buy |
+58,082
| New | +$1.37M | ﹤0.01% | 3853 |
|
|
2017
Q1 | – | Sell |
-36,723
| Closed | -$750K | – | 8247 |
|
|
2016
Q4 | $698K | Buy |
+36,723
| New | +$702K | ﹤0.01% | 4387 |
|
|
2016
Q3 | – | Sell |
-60,522
| Closed | -$906K | – | 7976 |
|
|
2016
Q2 | $906K | Buy |
+60,522
| New | +$761K | ﹤0.01% | 3687 |
|
|
2016
Q1 | – | Sell |
-5,116
| Closed | -$62K | – | 8415 |
|
|
2015
Q4 | $99K | Buy |
+5,116
| New | +$88.8K | ﹤0.01% | 6704 |
|
|
2015
Q3 | – | Sell |
-23,502
| Closed | -$514K | – | 9374 |
|
|
2015
Q2 | $514K | Buy |
+23,502
| New | +$474K | ﹤0.01% | 4924 |
|
Ken Griffin's FLXN Position: Q4 2021 in Review
Ken Griffin sold out of Flexion Therapeutics, Inc. (FLXN) in Q4 2021, closing a stake of 266,575 shares — an estimated $1.63M sold.
Ken Griffin first reported a position in FLXN in Q2 2015 and held it in 18 quarters. The position peaked at $5.55M in Q4 2019. 1 fund tracked by Wall St. Rank holds FLXN as of Q4 2021.
- Ken Griffin reported no remaining Flexion Therapeutics, Inc. position as of Q4 2021 after selling out during the quarter.
- Ken Griffin sold 266,575 Flexion Therapeutics, Inc. shares in Q4 2021, an estimated $1.63M.
- Ken Griffin first reported a position in Flexion Therapeutics, Inc. in Q2 2015 and held it in 18 quarters.
- Ken Griffin's Flexion Therapeutics, Inc. position peaked at $5.55M in Q4 2019.
- 1 fund tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q4 2021.
Based on Citadel Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.